Lymphocyte Markers As Predictors Of Responsiveness To Rituximab Among Patients With Idiopathic Nephrotic Syndrome

Sponsor
National University Health System, Singapore
Study ID
NCT03501459
Phase
PHASE3
Status
Unknown

Conditions

  • Nephrotic Syndrome

Eligibility Criteria

Sex
ALL
Age
1 Year - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to investigate if lymphocyte markers predict response to rituximab among patients with idiopathic nephrotic syndrome

Key Dates

Start date
Jun 30, 2008
Status verified
Aug 2019
Primary completion
Dec 31, 2020
Completion
Dec 31, 2025

Study Design

Enrollment
100 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Rituximab

Primary Outcome Measure

Response [ Time Frame: 3 months ]

Central Contacts

Related Studies